Intrathecal antibody production in two cases of yellow fever vaccine associated neurotropic disease in Argentina.

Authors:
Address: National Institute for Infectious Disease, National Administration of Laboratories, Buenos Aires, Argentina. piresfanny@gmail.com
Journal:

Publication:

abstract

During the period 2007-2008 several epizootics of yellow fever with dead of monkeys occurred in southeastern Brasil, Paraguay, and northeastern Argentina. In 2008 after a Yellow fever outbreak an exhaustive prevention campaign took place in Argentina using 17D live attenuated Yellow fever vaccine. This vaccine is considered one of the safest live virus vaccines, although serious adverse reactions may occur after vaccination, and vaccine-associated neurotropic disease are reported rarely. The aim of this study was to confirm two serious adverse events associated to Yellow fever vaccine in Argentina, and to describe the analysis performed to assess the origin of specific IgM against Yellow fever virus (YFV) in cerebrospinal fluid (CSF). Both cases coincided with the Yellow fever vaccine-associated neurotropic disease case definition, being clinical diagnosis longitudinal myelitis (case 1) and meningoencephalitis (case 2). Specific YFV antibodies were detected in CSF and serum samples in both cases by IgM antibody-capture ELISA. No other cause of neurological disease was identified. In order to obtain a conclusive diagnosis of central nervous system (CNS) infection the IgM antibody index (AI(IgM) ) was calculated. High AI(IgM) values were found in both cases indicating Intrathecal production of antibodies and, therefore, CNS post-vaccinal YFV infection could be definitively associated to YFV vaccination.

Related Articles
Longitudinal myelitis associated with yellow fever vaccination.
J Neurovirol. 2009
Longitudinal myelitis associated with yellow fever vaccination.
Chaves M, Riccio P, Patrucco L, Rojas JI, Cristiano E. J Neurovirol. 2009 Jul; 15(4):348-50.
West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
Vector Borne Zoonotic Dis. 2005
West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR. Vector Borne Zoonotic Dis. 2005 Summer; 5(2):137-45.
Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.
Vaccine. 2004
Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.
Kitchener S. Vaccine. 2004 Jun 2; 22(17-18):2103-5.
Review Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
Vaccine. 2011
Review Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T. Vaccine. 2011 Jun 20; 29(28):4544-55. Epub 2011 May 5.
Review [Yellow fever].
Przegl Epidemiol. 2004
Review [Yellow fever].
Wiercińska-Drapało A. Przegl Epidemiol. 2004; 58 Suppl 1:101-5.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.